Lipton RB, et al. Patient Global Impression of Change related to improvement in most bothersome symptom following treatment with eptinezumab. IHC-PO-167. IHC 2019, 5-8 sept. Dublin, Ierland.
Vergoeding selumetinib (Koselugo) voor kinderen met neurofibromatose type 1
mei 2024